Diabetic Foot Ulcer Treatment Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028, Segmented by Treatment (Wound Care Dressings, Biologics, Therapy Devices, Antibiotic Medications, and Others), By Ulcer Type (Neuropathic Ulcers, Ischemic Ulcers, and Neuroischemic Ulcers), By End User (Hospitals & Clinics, Ambulatory Care Centers, and Others), By Region, and Competition

Global diabetic foot ulcer treatment market is anticipated to witness an impressive growth during the forecast period. This can be ascribed to the increasingly leading of sedentary lifestyle along with consuming unhealthy food habits. Additionally, the growing demand for painless treatment with low cost coupled with increasing aesthetic consciousness among the population has significantly increased the demand for diabetic foot ulcer treatment across different parts of the globe. Additionally, the growing aging population across the globe which is susceptible to different kinds of ulcer diseases like foot ulcers is further expected to increase the demand for different dental contouring procedures, thereby fuelling the market growth through 2028. Besides, the growing prevalence of obesity because of leading unhealthy lifestyles across the globe is further expected to support the diabetic foot ulcer treatment market during the forecast period. Furthermore, the growing usage of proper medical equipment and medicines is further expected to increase the demand for diabetic foot ulcer treatment, thereby supporting market growth. According to the Centers for Disease Control and Prevention (CDC), 6 million people aged 18 years or older have prediabetes in the United States and 26.4 million people aged 65 years or older (48.8%) have prediabetes.

The treatment of diabetic foot ulcers typically involves a multidisciplinary approach, with a team of healthcare professionals working together to provide comprehensive care. The goal of treatment is to heal the ulcer and prevent complications such as infection and amputation. Prevention is also critical in the management of diabetic foot ulcers. Patients with diabetes should receive regular foot exams and education on proper foot care, including regular cleaning, moisturizing, and inspection for any signs of injury or infection. Patients should also wear appropriate footwear and avoid activities that put excessive pressure on the feet. One of the significant challenges in the treatment of diabetic foot ulcers is a lack of awareness among patients about the risks of developing foot ulcers and the importance of early detection and treatment. This lack of awareness often leads to delayed diagnosis and treatment, which can result in serious complications. The treatment of diabetic foot ulcers can be costly, especially for patients who require prolonged and extensive care. This can be a significant challenge for patients who lack access to affordable healthcare services, particularly in low- and middle-income countries. Access to healthcare facilities is a significant challenge in many parts of the world, particularly in rural and remote areas. This can make it difficult for patients with diabetic foot ulcers to receive the care and treatment they need in a timely manner. Although there have been significant advances in wound care products, access to these products is limited in many parts of the world. This can make it difficult for healthcare providers to provide the most effective treatment for diabetic foot ulcers. The lack of standardization in treatment protocols for diabetic foot ulcers can also be a challenge. This can lead to variations in care, which can result in different outcomes for patients.

Growing Prevalence of Diabetic Foot Ulcer

The rapidly increasing geriatric population is highly susceptible to chronic diseases such as different types of ulcers. This factor is expected to propel the diabetic foot ulcers treatment market in the next few years. An increase in the prevalence of peripheral vascular as well sugar-related diseases and other chronic diseases leading to rising risk of hospital-acquired pressure ulcers is expected to drive the segment during the forecast period. Constantly increasing obesity and peripheral artery diseases among developed and developing countries leads to decreased mobility and increased risk of acquiring chronic ulcers. Similarly, leading unhealthy lifestyle due to consuming junk food and alcohol people are affected with obesity and diabetes which will further create ulcer and enhanced the growth of the market during the forecast period. In 2019, 37.3 million Americans, or 11.3% of the population, had diabetes. Nearly 1.9 million Americans have type 1 diabetes, including about 244,000 children and adolescents.  Diabetic foot ulcers are more common because of growing incidence in both type of I and maturity onset diabetes among aging population in the developing region which will further propel the growth of the market during the forecast period.

The rising incidence of diabetes worldwide is one of the major drivers of the diabetic foot ulcer treatment market. According to the International Diabetes Federation, the number of people with diabetes worldwide is expected to increase from 463 million in 2019 to 700 million by 2045. Diabetes is a leading cause of foot ulcers, which require proper treatment and management to avoid complications such as amputations. The increasing geriatric population is another driver of the diabetic foot ulcer treatment market. Older adults are more likely to develop diabetes and are at a higher risk of developing diabetic foot ulcers. According to the World Health Organization, the global population aged 65 years and older is expected to double from 703 million in 2019 to 1.5 billion in 2050, which is expected to increase the demand for diabetic foot ulcer treatment. The growing trend of home healthcare is another driver of the diabetic foot ulcer treatment market. Many patients prefer to receive care at home rather than in hospitals or clinics, which is expected to increase the demand for homecare settings for diabetic foot ulcer treatment. Rising healthcare expenditure, especially in emerging economies, is driving the demand for diabetic foot ulcer treatment. Governments and private organizations are investing in improving healthcare infrastructure and promoting awareness about diabetes and its complications, which is expected to increase the demand for diabetic foot ulcer treatment.

Technological Advancement

Increasing investment and initiative by government organization for research and development sectors is a major factor driving the market across the globe. Increase in development of the new treatments and advancement in diabetic foot ulcers is expected to create a significant growth in the forecast period. For instance, in July 2019, AVITA Medical, g global regenerative medicine company, announced favourable results from an open label feasibility study of the RECELL Autologous Cell Harvesting Device for the treatment of Diabetic Foot Ulcers.  Increasing better hospital facility boosts the number of people opting for diabetic foot ulcer treatment. Advanced wound care is rapidly growing which will further attract the new players for investing in this market. Growing development in new biologic products, innovation and research in skin grafts will further drive the growth of the market over the years. There have been significant advancements in wound care products in recent years, including bioengineered skin substitutes, growth factors, and antimicrobial dressings. These advanced wound care products have shown promise in promoting healing and reducing the risk of infection in diabetic foot ulcers. Artificial intelligence (AI) has also emerged as a potential tool in the management of diabetic foot ulcers. AI technology can analyze patient data and provide real-time insights to healthcare providers, improving diagnosis and treatment. Many companies in the diabetic foot ulcer treatment market have formed collaborations and partnerships to develop new products and technologies. These collaborations have resulted in the development of innovative products and treatments for diabetic foot ulcers. Advances in wound care products such as bioengineered skin substitutes and growth factors are driving the growth of the diabetic foot ulcer treatment market. These products have proven to be effective in promoting wound healing and reducing the risk of infection.

Recent Development

• In January 2019, UPM launched a new advanced wound care product in the European market and FibDex is the product for wound dressing, created from wood based nanofibrillar cellulose to receive regulatory approval and to be awarded with a CE mark.
• Launched in 2020 by Urgo Medical, UrgoStart Contact is a bioactive wound dressing that contains a protease-modulating matrix. The product is designed to promote wound healing and reduce the risk of infection in diabetic foot ulcers.
• Launched in 2019 by Covalon Technologies Ltd, Agilus HealX is an antimicrobial wound dressing that incorporates silver and iodine to prevent infection in diabetic foot ulcers. The product is designed to be used in conjunction with standard wound care protocols.
• Launched in 2018 by Podimetrics, the Remote Temperature Monitoring System is a telemedicine platform that uses temperature sensors to detect early signs of diabetic foot ulcers. The system allows healthcare providers to remotely monitor patients and intervene before the ulcer becomes severe.

Download Free Sample Report

Market Segmentation

Global diabetic foot ulcer treatment market can be segmented by treatment, ulcer treatment, End User and by region. Based on treatment, the market can be segmented into Wound Care Dressings, Biologics, Therapy Devices, Antibiotic Medications, and Others. Based on ulcer treatment, the market can be differentiated into Neuropathic Ulcers, Ischemic Ulcers, and Neuroischemic Ulcers. Based on End User, the market can be grouped into Hospitals & Clinics, Ambulatory Care Centers, and Others. Regionally, North America dominated the market among Asia Pacific, Europe, Middle East & Africa, and South America. Among the different countries, United States dominated the global diabetic foot ulcer treatment market.

Market Players

3M Company, Medtronic Plc, ConvaTec, Inc., Coloplast Corporation, Smith & Nephew Plc, B Braun Melsungen AG, Medline Industries, Inc., Organogenesis, Inc., Molnlycke Health Care AB, Acelity L.P., Inc. are some of the leading players operating in the Global Diabetic Foot Ulcer Treatment Market.

Report Scope:

In this report, global diabetic foot ulcer treatment market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

• Diabetic Foot Ulcer Treatment Market, By Treatment:

o      Wound Care Dressings

o      Biologics

o      Therapy Devices

o      Antibiotic Medications

o      Others

             ·    Diabetic Foot Ulcer Treatment Market, By Ulcer Treatment:

o     Neuropathic Ulcers

o     Ischemic Ulcers

o     Neuroischemic Ulcers

• Diabetic Foot Ulcer Treatment Market, By End User:

o      Hospitals & Clinics

o      Ambulatory Care Centers

o      Others

            ·      Diabetic Foot Ulcer Treatment Market, By Region:

o      North America

§  United States

§  Canada

§  Mexico

o      Europe

§  France

§  Germany

§  United Kingdom

§  Italy

§  Spain

o      Asia Pacific

§  China

§  India

§  Japan

§  South Korea

§  Australia

o      South America

§  Brazil

§  Argentina

§  Colombia

o      Middle East & Africa

§  South Africa

§  Saudi Arabia

§  UAE

§  Turkey

§  Egypt

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in Global Diabetic Foot Ulcer Treatment Market.

Available Customizations:

With the given market data, TechSci Research offers customizations according to a company’s specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).